In PPMI, most individuals with clinically diagnosed early PDmet criteria for stage 3 (65% sporadic PD, 61% LRRK2 PD, and 59% GBA PD);similarly, 66% PASADENA and 55% SPARK participants were stage 3. Here, LRRK2 is linked to Parkinson disease.